30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 24 Intellectual Property, Patents, and Regulatory Exclusivities

This podcast episode explores intellectual property rights in cannabinoid and psychedelic drug development. The discussion covers various aspects of patent protection, including novel drug formulations, extraction processes, and synthetic analogs. The speakers examine the tension between protecting pharmaceutical innovations and ensuring treatment accessibility, while also addressing the ethical considerations of patenting naturally-derived compounds. The episode delves into topics like orphan drug status for rare diseases and emerging alternative models like open-source research platforms. Throughout the conversation, there's a focus on balancing commercial interests with equitable access to these potentially groundbreaking therapies.